CA2124957A1 - Methodes de production de fragments solubles et purifies du recepteur du facteur de croissance derive des plaquettes de type b et a humain - Google Patents

Methodes de production de fragments solubles et purifies du recepteur du facteur de croissance derive des plaquettes de type b et a humain

Info

Publication number
CA2124957A1
CA2124957A1 CA 2124957 CA2124957A CA2124957A1 CA 2124957 A1 CA2124957 A1 CA 2124957A1 CA 2124957 CA2124957 CA 2124957 CA 2124957 A CA2124957 A CA 2124957A CA 2124957 A1 CA2124957 A1 CA 2124957A1
Authority
CA
Canada
Prior art keywords
cell line
pdgf
type
delta
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2124957
Other languages
English (en)
Inventor
David Wolf
James E. Tomlinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2124957A1 publication Critical patent/CA2124957A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2124957 1991-12-02 1992-12-01 Methodes de production de fragments solubles et purifies du recepteur du facteur de croissance derive des plaquettes de type b et a humain Abandoned CA2124957A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80179491A 1991-12-02 1991-12-02
US07/801,794 1991-12-02

Publications (1)

Publication Number Publication Date
CA2124957A1 true CA2124957A1 (fr) 1993-06-10

Family

ID=25182041

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2124957 Abandoned CA2124957A1 (fr) 1991-12-02 1992-12-01 Methodes de production de fragments solubles et purifies du recepteur du facteur de croissance derive des plaquettes de type b et a humain

Country Status (9)

Country Link
EP (1) EP0619836A4 (fr)
JP (1) JPH07501702A (fr)
AU (1) AU675924B2 (fr)
CA (1) CA2124957A1 (fr)
NO (1) NO942032L (fr)
NZ (1) NZ246256A (fr)
PL (1) PL171788B1 (fr)
RU (1) RU94046397A (fr)
WO (1) WO1993011223A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228600B1 (en) 1992-07-20 2001-05-08 The United States Of America As Represented By The Department Of Health And Human Services Immunoassays for the alpha platelet-derived growth factor receptor
US7252929B2 (en) 1989-02-09 2007-08-07 United States Of America, As Represented By The Secretary, Dept Of Health & Human Services Methods for identifying alpha PDGFR agonists and antagonists
US5468468A (en) * 1989-02-09 1995-11-21 The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services Method for making a monoclonal antibody, monoclonal antibodies to α PD
EP0584082B1 (fr) * 1991-01-31 2000-05-31 Cor Therapeutics, Inc. Domaines de la region extracellulaire de polypeptides recepteurs du facteur de croissance derive de plaquettes humaines
US5817310A (en) 1991-12-02 1998-10-06 Cor Therapeutics, Inc. Inhibitory immunoglobulin polypeptides to human PDGF beta receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE140963T1 (de) * 1988-01-22 1996-08-15 Zymogenetics Inc Verfahren zur herstellung von sekretierten rezeptoranalogen
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor
AU2899489A (en) * 1988-02-05 1989-08-10 Guardian Technologies, Inc. Apparatus for delivering a breath sample to a solid state sensor
EP0584082B1 (fr) * 1991-01-31 2000-05-31 Cor Therapeutics, Inc. Domaines de la region extracellulaire de polypeptides recepteurs du facteur de croissance derive de plaquettes humaines
IE920318A1 (en) * 1991-01-31 1992-07-29 Univ California Human platelet-derived growth factor receptors

Also Published As

Publication number Publication date
AU675924B2 (en) 1997-02-27
PL171788B1 (pl) 1997-06-30
NO942032D0 (no) 1994-06-01
RU94046397A (ru) 1996-10-10
JPH07501702A (ja) 1995-02-23
EP0619836A1 (fr) 1994-10-19
WO1993011223A1 (fr) 1993-06-10
NZ246256A (en) 1996-01-26
EP0619836A4 (en) 1996-12-04
NO942032L (no) 1994-06-01
AU3236493A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
US5888773A (en) Method of producing single-chain Fv molecules
ES2315016T3 (es) Moleculas llamadas b7l-1.
EP0773997A2 (fr) Ligand de htk
US20020150574A1 (en) Antibodies against SEMP1 (p23)
JPH05268982A (ja) 骨形成作用を有する新規な蛋白質およびその製造法
US20030162238A1 (en) Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
JP3779989B2 (ja) リンパ抗原ｃｄ３０
US5753502A (en) Neuron-specific ICAM-4 promoter
JPH10505068A (ja) 新規ヘモポイエチン受容体
JP4671371B2 (ja) 脊椎動物Ｓｍｏｏｔｈｅｎｅｄタンパク質
CA2124957A1 (fr) Methodes de production de fragments solubles et purifies du recepteur du facteur de croissance derive des plaquettes de type b et a humain
US20040248257A1 (en) SPEX compositions and methods of use
KR20130048193A (ko) 발현 벡터
JPH06211898A (ja) 神経α−カテニン
JP3288716B2 (ja) ヒト接着分子オクルディン
JP3349514B2 (ja) Ｉｃａｍ−４物質及び方法
US6225086B1 (en) Polynucleotides encoding ankyrin proteins
US6670135B1 (en) Semaphorin polypeptides
WO1997031110A1 (fr) Molecule de la famille des genes de transfert f, polynucleotide codant pour cette molecule et anticorps actif contre cette molecule
JP2997770B2 (ja) ウシ由来ｃ−Ｋｉｔタンパク質に対するモノクローナル抗体とそれを用いた細胞分離法
US5852170A (en) ICAM-4 materials and methods
WO1989011533A1 (fr) Gene clone exprimant des anticorps reagissant avec le cancer ovarien chez la femme
Renaud Molecular analysis of sodium, potassium-ATPase subunit assembly
EP0731836A1 (fr) Recepteur p95 de l'ovocyte du poussin (recepteur de lipomicrons/vitellogenine)
JPH06184199A (ja) 低分子量Ｇ蛋白質ｒａｂ３Ａ ｐ２５の標的蛋白質

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead